{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:46:24Z","timestamp":1773938784425,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"DOI":"10.7759\/cureus.105501","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:25:52Z","timestamp":1773933952000},"source":"Crossref","is-referenced-by-count":0,"title":["Immune Hyperactivation in Epstein-Barr Virus (EBV)-Driven T-cell Lymphoproliferation: A Pediatric Case of Hemophagocytic Syndrome"],"prefix":"10.7759","author":[{"given":"Nour El Houda","family":"Fakhri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karima","family":"Ryouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El Alaoui","family":"Mounia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noufissa","family":"Benajiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-008-0640-7","article-title":"Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients","volume":"453","author":"Park S","year":"2008","unstructured":"Park S, Kim K, Kim WS, Yoo KH, Koo HH, Ko YH. Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients. Virchows Arch. 2008, 453:155-63. 10.1007\/s00428-008-0640-7","journal-title":"Virchows Arch"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0053","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone A","year":"2008","unstructured":"Carbone A, Gloghini A, Dotti G. Epstein-Barr virus-associated lymphoproliferative disorders: classification and treatment. Oncologist. 2008, 13:577-85. 10.1634\/theoncologist.2008-0053","journal-title":"Oncologist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.3.865","article-title":"Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes","volume":"146","author":"Fischer E","year":"1991","unstructured":"Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J Immunol. 1991, 146:865-9. 10.4049\/jimmunol.146.3.865","journal-title":"J Immunol"},{"key":"ref4","unstructured":"https.\/\/somipev.ma\/somibos\/wp-content\/uploads\/2025\/11\/13Congres_somipev_resumes-1.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura H","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S, et al.. EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012, 119:673-86. 10.1182\/blood-2011-10-381921","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00417","article-title":"Overview of EBV-associated T\/NK-cell lymphoproliferative diseases","volume":"6","author":"Kimura H","year":"2018","unstructured":"Kimura H, Fujiwara S. Overview of EBV-associated T\/NK-cell lymphoproliferative diseases. Front Pediatr. 2018, 6:417. 10.3389\/fped.2018.00417","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen JI","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009, 20:1472-82. 10.1093\/annonc\/mdp064","journal-title":"Ann Oncol"},{"key":"ref8","article-title":"Hemophagocytic syndromes of genetic origin [Article in French]","volume":"1","author":"Nehme N","year":"2010","unstructured":"Nehme N, Pachlopnik-Schmid J, de Saint-Basile G. Hemophagocytic syndromes of genetic origin [Article in French]. Rev M\u00e9d G\u00e9n\u00e9t H\u00e9matol. 2010, 1:34-44.","journal-title":"Rev M\u00e9d G\u00e9n\u00e9t H\u00e9matol"},{"key":"ref9","article-title":"EBV-positive T-cell lymphoproliferative disorders of childhood","author":"Quintanilla-Mart\u00ednez L","year":"2017","unstructured":"Quintanilla-Mart\u00ednez L, Kimura H, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, 2017."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura H","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H, et al.. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis. 2003, 187:527-33. 10.1086\/367988","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen JI","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, et al.. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011, 117:5835-49. 10.1182\/blood-2010-11-316745","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.505","article-title":"Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?","volume":"16","author":"Kimura H","year":"2006","unstructured":"Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?. Rev Med Virol. 2006, 16:251-61. 10.1002\/rmv.505","journal-title":"Rev Med Virol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12293","article-title":"Advances in understanding the pathogenesis of HLH","volume":"161","author":"Usmani GN","year":"2013","unstructured":"Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013, 161:609-22. 10.1111\/bjh.12293","journal-title":"Br J Haematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-52. 10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15973","article-title":"Virus-triggered secondary hemophagocytic lymphohistiocytosis","volume":"110","author":"Imashuku S","year":"2021","unstructured":"Imashuku S, Morimoto A, Ishii E. Virus-triggered secondary hemophagocytic lymphohistiocytosis. Acta Paediatr. 2021, 110:2729-36. 10.1111\/apa.15973","journal-title":"Acta Paediatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/460344-immune-hyperactivation-in-epstein-barr-virus-ebv-driven-t-cell-lymphoproliferation-a-pediatric-case-of-hemophagocytic-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:25:53Z","timestamp":1773933953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/460344-immune-hyperactivation-in-epstein-barr-virus-ebv-driven-t-cell-lymphoproliferation-a-pediatric-case-of-hemophagocytic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105501","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}